Application
Black line: Control Antigen (100 ng);
Purple line: Antigen(10ng);
Blue line: Antigen (50 ng);
Red line: Antigen (100 ng);
Application
Figure 2:Western blot analysis using TFAP2A mAb against human TFAP2A (AA: 1-100) recombinant protein. (Expected MW is 37 kDa)
Application
Figure 3:Western blot analysis using TFAP2A mAb against HEK293 (1) and TFAP2A (AA: 1-100)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 4:Western blot analysis using TFAP2A mouse mAb against Hela (1), MCF-7 (2), Cos7 (3), A431 (4), HCT116 (5), NIH/3T3 (6), and PC12 (7) cell lysate.
Application
Figure 5:Flow cytometric analysis of Hela cells using TFAP2A mouse mAb (green) and negative control (red).
Application
Figure 6:Immunohistochemical analysis of paraffin-embedded ovarian cancer tissues using TFAP2A mouse mAb with DAB staining.
Application
Figure 7:Immunohistochemical analysis of paraffin-embedded TFAP2A tissues using endometrial cancer mouse mAb with DAB staining.
Application
Figure 8:Flow cytometric analysis of MCF-7 cells using TFAP2A mouse mAb (green) and negative control (red).